ClinVar Miner

Submissions for variant NM_000487.6(ARSA):c.1150G>A (p.Glu384Lys)

gnomAD frequency: 0.00001  dbSNP: rs74315479
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000723624 SCV000110796 pathogenic not provided 2013-04-18 criteria provided, single submitter clinical testing
Invitae RCV000078936 SCV000752522 pathogenic Metachromatic leukodystrophy 2023-12-27 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 384 of the ARSA protein (p.Glu384Lys). RNA analysis indicates that this missense change induces altered splicing and likely disrupts the C-terminus of the protein. This variant is present in population databases (rs74315479, gnomAD 0.007%). This missense change has been observed in individual(s) with metachromatic leukodystrophy (PMID: 7906588, 15375602, 19021637, 20339381, 26462614). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.1144G>A or E382K. ClinVar contains an entry for this variant (Variation ID: 3084). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ARSA protein function with a negative predictive value of 95%. Studies have shown that this missense change results in exon 7 skipping and introduces a new termination codon (PMID: 15375602). However the mRNA is not expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic.
Counsyl RCV000078936 SCV000793445 likely pathogenic Metachromatic leukodystrophy 2017-08-18 criteria provided, single submitter clinical testing
Mendelics RCV000078936 SCV001141461 pathogenic Metachromatic leukodystrophy 2019-05-28 criteria provided, single submitter clinical testing
GeneDx RCV000723624 SCV002073989 likely pathogenic not provided 2021-12-06 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 15375602, 7906588, 32632536)
OMIM RCV000003230 SCV000023388 pathogenic Arylsulfatase a pseudodeficiency, intermediate 1994-09-01 no assertion criteria provided literature only
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000723624 SCV001809416 likely pathogenic not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000723624 SCV001926821 pathogenic not provided no assertion criteria provided clinical testing
Natera, Inc. RCV000078936 SCV002081642 pathogenic Metachromatic leukodystrophy 2021-05-06 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.